Lei Jiang

6PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 06, 2021
Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study.

Qian Feng, Liang-Jie Tang, Ding-Hai Luo

|Nov 14, 2021
Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.

Jiawen Yang, Jiajie Mo, Juji Dai

|Feb 11, 2021
BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.

Lifang Luo, Wenjing Sun, Weijian Zhu

|Jun 18, 2020
Sodium Butyrate Selectively Kills Cancer Cells and Inhibits Migration in Colorectal Cancer by Targeting Thioredoxin-1.

Wenqi Wang, Daoquan Fang, Hao Zhang

|Mar 27, 2019
Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer.

Wenjing Shang, Zhongdong Xie, Fengying Lu

|Feb 01, 2018
Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.

Zhigui Zuo, Peili Zhang, Feiyan Lin

Pageof 1

Frequent Collaborators

1 joint publications

Lingli Chen

1 joint publications

Wenqi Wang

1 joint publications

Jimei Du

1 joint publications

Lifang Luo